576 / 1173
Conclusions from EPO Cochrane review in
Head and Neck 2009
Erythropoietic proteins, as an adjuvant
treatment with (chemo) radiotherapy,
worsens survival for patients with head
and neck cancer.
Lambin P et al Cochrane review 2009